These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Outcomes of a protocol-based management for zone 1 retinopathy of prematurity: the Indian Twin Cities ROP Screening Program report number 2. Jalali S; Kesarwani S; Hussain A Am J Ophthalmol; 2011 Apr; 151(4):719-724.e2. PubMed ID: 21257156 [TBL] [Abstract][Full Text] [Related]
25. Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention. Coats DK Trans Am Ophthalmol Soc; 2005; 103():281-312. PubMed ID: 17057808 [TBL] [Abstract][Full Text] [Related]
26. Refractive outcomes of lens-sparing vitrectomy for retinopathy of prematurity. Carvounis PE; Poll J; Weikert MP; Wilhelmus K; Lakhanpal RR; Holz ER Arch Ophthalmol; 2010 Jul; 128(7):843-6. PubMed ID: 20625043 [TBL] [Abstract][Full Text] [Related]
27. Lensectomy and vitrectomy with and without intravitreal triamcinolone acetonide for vascularly active stage 5 retinal detachments in retinopathy of prematurity. Lakhanpal RR; Fortun JA; Chan-Kai B; Holz ER Retina; 2006 Sep; 26(7):736-40. PubMed ID: 16963844 [TBL] [Abstract][Full Text] [Related]
28. Retinal detachment with macular holes in infants with retinopathy of prematurity. Ahmad OF; Hirose T Arch Ophthalmol; 2005 Jan; 123(1):54-7. PubMed ID: 15642812 [TBL] [Abstract][Full Text] [Related]
29. Long-term follow up of visual acuity in eyes with stage 5 retinopathy of prematurity after closed vitrectomy. Fuchino Y; Hayashi H; Kono T; Ohshima K Am J Ophthalmol; 1995 Sep; 120(3):308-16. PubMed ID: 7661202 [TBL] [Abstract][Full Text] [Related]
30. Anatomical success rate after primary three-port lens-sparing vitrectomy in stage 5 retinopathy of prematurity. Lakhanpal RR; Sun RL; Albini TA; Holz ER Retina; 2006 Sep; 26(7):724-8. PubMed ID: 16963842 [TBL] [Abstract][Full Text] [Related]
31. Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser. Isaac M; Mireskandari K; Tehrani N J AAPOS; 2015 Apr; 19(2):140-4. PubMed ID: 25892041 [TBL] [Abstract][Full Text] [Related]
34. [Buffering capacity of the vitreous body in aggressive posterior retinopathy of prematurity]. Amkhanitskaia LI; Sidorenko EI; Nikolaeva GV; Kuznetsova IuD Vestn Oftalmol; 2014; 130(3):32-4. PubMed ID: 25098119 [TBL] [Abstract][Full Text] [Related]
35. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results]. Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695 [TBL] [Abstract][Full Text] [Related]
36. Recurrent vitreous hemorrhage associated with regressed retinopathy of prematurity in a 47-year-old patient: a case report. Takeyama M; Iwaki M; Zako M J Med Case Rep; 2014 Jun; 8():183. PubMed ID: 24916359 [TBL] [Abstract][Full Text] [Related]
37. Outcome of solid-state 532 nm green laser in high-risk retinopathy of prematurity at a tertiary care centre in India. Chhabra K; Kaur P; Singh K; Aggarwal A; Chalia D Int Ophthalmol; 2018 Feb; 38(1):287-291. PubMed ID: 28204988 [TBL] [Abstract][Full Text] [Related]
38. Anatomical and visual results of vitreous surgery for advanced retinopathy of prematurity. Choi MY; Yu YS Korean J Ophthalmol; 1998 Jun; 12(1):60-7. PubMed ID: 9753952 [TBL] [Abstract][Full Text] [Related]
39. Anatomic success rate after 3-port lens-sparing vitrectomy in stage 4A or 4B retinopathy of prematurity. Lakhanpal RR; Sun RL; Albini TA; Holz ER Ophthalmology; 2005 Sep; 112(9):1569-73. PubMed ID: 16005974 [TBL] [Abstract][Full Text] [Related]